Vaccine response and aging in people with HIV
Part of Immune system & allergy, Infections clinical trials.
This study is for people living with HIV who are 18 or older and on HIV medication. Researchers want to learn how the immune system and vaccine response change as people age, and will give a pneumococcal (pneumonia) vaccine to study that.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have HIV and are taking HIV medications
- Your HIV viral load has been under 200 in the last year
- You do not have another serious condition that weakens the immune system
- You are not pregnant at the start of the study
- You are able and willing to have blood drawn and follow the study schedule
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how age affects the immune system's response to a pneumococcal vaccine. Researchers want to compare younger and older adults to see if immune cells change with age.
This trial studies how safe and how well the body’s immune system responds to meningococcal and pneumococcal vaccines in adults living with HIV. It may help confirm these vaccines work properly and are safe for people on HIV treatment.
This study tests a new pneumococcal vaccine to see if it is safe and triggers a good immune response. It may help protect you from infections like pneumonia, but you must not have had any pneumococcal vaccine since age 5.
This trial is testing a new pneumonia vaccine (called PCV21) in older veterans with weakened immune systems who have already had an older pneumonia shot (PPSV23). It aims to see if the new vaccine can offer better protection against pneumonia and related infections.
This trial tests a new vaccine (called PCV26) in people 60 and older. The goal is to see if the vaccine is safe and to gather early information on how it works.
This study tests a new pneumococcal vaccine (PCV15) to see how well it protects against carrying the bacteria that can cause pneumonia. Healthy adults aged 18–50 who have not had a pneumococcal vaccine in the last 5 years may join.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.